Serhat Ünal

InstitutionHacettepe University Faculty of Medicine
AddressAnkara
Turkey
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 4 publications in April 2021
    All Publications
    Bar chart showing 96 publications over 20 distinct years, with a maximum of 13 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rudvan Al LI, Sönmezer MÇ, Ünal S. RNA-Based COVID-19 vaccine candidates with clinical phase trials in progress Turk J Med Sci. 2021 12 17; 51(SI-1):3246-3252. PMID: 34365779.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Inkaya AÇ, Kara E, Çalik Basaran N, Sahin TK, Uyaroglu OA, Uzun Ö, Ünal S. Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients. Turk J Med Sci. 2021 Aug 16. PMID: 34392669.
      Citations:    Fields:    
    3. Tanriover MD, Doganay HL, Akova M, Güner HR, Azap A, Akhan S, Köse S, Erdinç FS, Akalin EH, Tabak ÖF, Pullukçu H, Batum Ö, Simsek Yavuz S, Turhan Ö, Yildirmak MT, Köksal I, Tasova Y, Korten V, Yilmaz G, Çelen MK, Altin S, Çelik I, Bayindir Y, Karaoglan I, Yilmaz A, Özkul A, Gür H, Unal S. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021 07 17; 398(10296):213-222. PMID: 34246358.
      Citations: 56     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    4. Çalik Basaran N, Uyaroglu OA, Telli Dizman G, Özisik L, Sahin TK, Tas Z, Inkaya AÇ, Karahan S, Alp S, Alp A, Metan G, Zarakol P, Sain Güven G, Öz SG, Topeli A, Uzun Ö, Akova M, Ünal S. Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU Turk J Med Sci. 2021 04 30; 51(2):411-420. PMID: 32718127.
      Citations: 3     Fields:    Translation:Humans
    5. Hagens A, Inkaya AÇ, Yildirak K, Sancar M, van der Schans J, Acar Sancar A, Ünal S, Postma M, Yegenoglu S. COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey. Vaccines (Basel). 2021 Apr 18; 9(4). PMID: 33919586.
      Citations: 2     
    6. Tavukcuoglu E, Horzum U, Cagkan Inkaya A, Unal S, Esendagli G. Functional responsiveness of memory T cells from COVID-19 patients. Cell Immunol. 2021 07; 365:104363. PMID: 33905951.
      Citations: 4     Fields:    Translation:HumansCells
    7. Akova M, Unal S. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Apr 13; 22(1):276. PMID: 33849629.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    8. Acar AC, Er AG, Burduroglu HC, Sülkü SN, Aydin Son Y, Akin L, Ünal S. Projecting the course of COVID-19 in Turkey: A probabilistic modeling approach Turk J Med Sci. 2021 02 26; 51(1):16-27. PMID: 32530587.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. UyaroGlu OA, BaSaran NÇ, ÖziSik L, DIzman GT, EroGlu I, SahIn TK, TaS Z, Inkaya AÇ, TanriÖver MD, Metan G, GÜven GS, Ünal S. Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study. Int J Qual Health Care. 2021 Feb 20; 33(1). PMID: 33104780.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    10. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Hammitt LL, Türeci Ö, Nell H, Schaefer A, Ünal S, Tresnan DB, Mather S, Dormitzer PR, Sahin U, Jansen KU, Gruber WC. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 12 31; 383(27):2603-2615. PMID: 33301246.
      Citations: 2292     Fields:    Translation:HumansCTClinical Trials
    11. Ayaz CM, Dizman GT, Metan G, Alp A, Unal S. Out-patient management of patients with COVID-19 on home isolation. Infez Med. 2020 Sep 01; 28(3):351-356. PMID: 32920570.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    12. Kara E, Demirkan K, Unal S. Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19. Int J Antimicrob Agents. 2020 Sep; 56(3):106123. PMID: 32738307.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    13. Voss A, Coombs G, Unal S, Saginur R, Hsueh PR. Publishing in face of the COVID-19 pandemic. Int J Antimicrob Agents. 2020 Jul; 56(1):106081. PMID: 32674930.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    14. Göker H, Aladag Karakulak E, Demiroglu H, Ayaz Ceylan ÇM, Büyükasik Y, Inkaya AÇ, Aksu S, Sayinalp N, Haznedaroglu IC, Uzun Ö, Akova M, Özcebe OI, Ünal S. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome Turk J Med Sci. 2020 06 23; 50(4):679-683. PMID: 32496734.
      Citations: 37     Fields:    Translation:Humans
    15. Kara E, DemIrkan K, Ünal S. Knowledge and Attitudes Among Hospital Pharmacists About COVID-19. Turk J Pharm Sci. 2020 Jun; 17(3):242-248. PMID: 32636699.
      Citations: 7     
    16. Simsek Yavuz S, Ünal S. Antiviral treatment of COVID-19 Turk J Med Sci. 2020 04 21; 50(SI-1):611-619. PMID: 32293834.
      Citations: 63     Fields:    Translation:HumansCellsPHPublic Health
    Ünal's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (196)
    Explore
    _
    Co-Authors (112)
    Explore
    _
    Similar People (60)
    Explore
    _